Eli Lilly Says HHS Ignores Drug Discount Double-Dipping

By Lauren Berg · November 15, 2024, 11:25 PM EST

Eli Lilly & Co. claims the U.S. Department of Health and Human Services is unlawfully blocking its efforts to crack down on hospitals the company alleges are double-dipping on medication discounts...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

ELI LILLY AND COMPANY et al v. XAVIER BECERRA et al

Case Number

Court

District Of Columbia

Nature of Suit

Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

November 14, 2024

Recent Articles By Lauren

December 20, 2024
Independent Health Inks $98M Deal For Medicare Overcharges
December 16, 2024
UnitedHealthcare Shooting Suspect Hires Ex-NYC Prosecutor
November 26, 2024
Trump Taps Bhattacharya For National Institutes Of Health
November 20, 2024
Musk, Ramaswamy Say High Court Rulings OK Federal Cuts
November 12, 2024
J&J Says HHS Is Thwarting Transparency Of Drug Discounts
October 30, 2024
FDA Didn't Flub Approval In Orphan Drug Case, DC Court Says
October 18, 2024
Oklahoma Brings Title X Funding Cut Fight To Justices
October 11, 2024
Feds Target Ill. Hospital CEO As $19M Theft Probe Widens
October 11, 2024
Quinn Emanuel Gets Trimmed $92M Fee In ACA Cases
September 30, 2024
Takeda End Payors, Direct Buyers Win Antitrust Class Cert.